Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
20.72
+0.67 (3.34%)
At close: Oct 13, 2025, 4:00 PM EDT
20.51
-0.21 (-1.01%)
After-hours: Oct 13, 2025, 6:08 PM EDT
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $2.48 billion as of October 13, 2025. Its market cap has increased by 133.56% in one year.
Market Cap
2.48B
Enterprise Value
2.40B
1-Year Change
133.56%
Ranking
Category
Stock Price
$20.72
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $2.48B, an increase of 217.69%. That is a compound annual growth rate of 22.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 2.40B | 47.45% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | 1.23B | 56.71% |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |